(Q24594944)

Geoffrey K Mitchell

3

0 references

Philip Schluter

Philip J Schluter

10

0 references

Chris Del Mar

Chris del Mar

9

0 references

Paul A. Scuffham

Paul A Scuffham

1

0 references

Paul P. Glasziou

Paul Glasziou

11

0 references

author name string

Michael J Yelland

4

0 references

Norma Vine

5

0 references

Christopher J Poulos

6

0 references

Peter I Pillans

7

0 references

Guy Bashford

Journal of General Internal Medicine

8

0 references

language of work or name

English

0 references

publication date

September 2010

0 references

published in

0 references

volume

25

0 references

issue

9

0 references

page(s)

906-13

0 references

cites work

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

N of 1 trials in diabetes: making individual therapeutic decisions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Using n-of-1 trials as a clinical tool to improve prescribing.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Current issues in the design and interpretation of clinical trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Are N-of-1 trials an economically viable option to improve access to selected high cost medications? The Australian experience

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11606-010-1352-7

N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Medication adherence trends with statins

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

The direct medical cost of diabetes in Israel

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917656

Determining optimal therapy--randomized trials in individual patients

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20386995

12 December 2020

inferred from PubMed ID database lookup

Efficacy of analgesics in chronic pain: a series of N-of-1 studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20386995

12 December 2020

inferred from PubMed ID database lookup

Using N-of-1 trials in evidence-based clinical practice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20386995

12 December 2020

inferred from PubMed ID database lookup

Using N-of-1 Trials in Evidence-Based Clinical Practice—Reply

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11606-010-1352-7

7 January 2021

inferred from DOI database lookup

Microarrays, Empirical Bayes and the Two-Groups Model

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11606-010-1352-7

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/S11606-010-1352-7

0 references

Dimensions Publication ID

1043342943

0 references

Fatcat ID

release_ihvjqmcxl5brxdtqoi4wt7bsqi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ihvjqmcxl5brxdtqoi4wt7bsqi

24 November 2022